Feb 26
#44 Rethinking medical device safety, part 2 – Omar Aimer
Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and form ... Show More
20m 43s
Jan 28
#43 Rethinking medical device safety, part 1 – Omar Aimer
Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can leave patients vulnerable. In this two-part episode, Omar Aimer, president of ISoP and ... Show More
22m 4s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
<p>In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ... Show More
24m 12s
Mar 2025
Uncovering Strengths to Navigate ADHD Challenges
<p></p>
<p>In this episode, Ash and Dusty revisit the critical topic of strengths in the context of ADHD. They explore how individuals with ADHD often focus on their challenges, overshadowing their unique strengths. Through coaching insights and real-life examples, they emphasize ... Show More
29m 56s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;">This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. </ ... Show More
30m 11s
Mar 2024
Ep. 422 Pathology 101: Solid Advice for Percutaneous Biopsies with Dr. Andrew Sholl
In this episode of the BackTable Podcast, host Dr. Chris Beck interviews guest Dr. Andrew Sholl, who demystifies the ins and outs of percutaneous biopsies and their impact on diagnoses. Dr. Scholl is a pathologist at LCMC Health in New Orleans, Louisiana.
Dr. Sholl emphasizes th ... Show More
56m 5s
Aug 2025
Communicating HR’s Value Through Data
In this episode of People and Strategy at SHRM25 in San Diego, Thanh Giddarie, director of HR for MIT Health at the Massachusetts Institute of Technology, discusses how organizations can leverage data to communicate the value of HR. Giddarie shares her journey from marketing to H ... Show More
24m 39s
Sep 2025
PsychEd Episode 70: Goals of Care Conversations with Dr. Tavis Apramian
Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers goals of care conversations.Our guest for this episode is Dr. Tavis Apramian, a clinician-investigator in the Department of Family & Community Medicine (DFCM) at the Universi ... Show More
1h 22m
Sep 2025
Sep 26 2025 This Week in Cardiology
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for ... Show More
22m 50s
Feb 2024
Laurence Cox et al., "Handbook of Research Methods and Applications for Social Movements" (Edward Elgar, 2024)
Addressing practice-oriented questions, this handbook engages with both theoretical and political dimensions, unpacking the multidimensional nature of social movement research for new and established scholars alike and for movement-based as well as academic researchers across man ... Show More
34m 5s
Send a text message to the show! While structured data elements such as patient identifier, medicine name and reaction, are fundamental for adverse event reporting, they may not capture all relevant details. This is where the narrative fields come in, allowing reporters to disclose important contextual information, such as the patient’s full clinical course. ... Show More
<p class="" style="white-space:pre-wrap;">In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy.</p><p class="" style="white-space:pre-wrap;">Episode contents: </p><p class="" style="white-space:pre-wrap;">- How do we assess ... Show More
